HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 35.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,615 shares of the company’s stock after selling 17,635 shares during the period. State of New Jersey Common Pension Fund D’s holdings in HealthEquity were worth $2,811,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Cape Investment Advisory Inc. acquired a new stake in HealthEquity in the fourth quarter valued at $27,000. Rise Advisors LLC bought a new stake in shares of HealthEquity in the 1st quarter worth about $28,000. International Assets Investment Management LLC acquired a new stake in shares of HealthEquity in the 2nd quarter valued at about $35,000. YHB Investment Advisors Inc. bought a new position in shares of HealthEquity during the first quarter worth about $40,000. Finally, Fidelis Capital Partners LLC acquired a new position in HealthEquity in the first quarter worth about $42,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HQY. Raymond James upped their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Friday, June 7th. Wells Fargo & Company raised their price objective on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a research note on Thursday, June 20th. Bank of America decreased their price objective on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft increased their target price on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, August 30th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $103.83.

HealthEquity Stock Performance

Shares of HQY stock opened at $77.54 on Thursday. HealthEquity, Inc. has a 12-month low of $61.81 and a 12-month high of $88.26. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The firm has a market capitalization of $6.75 billion, a price-to-earnings ratio of 85.65, a price-to-earnings-growth ratio of 1.19 and a beta of 0.52. The business has a 50 day simple moving average of $76.08 and a 200 day simple moving average of $79.37.

Insider Transactions at HealthEquity

In related news, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, Director Frank Corvino sold 7,705 shares of the company’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the completion of the sale, the director now owns 6,070 shares in the company, valued at $497,072.30. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the business’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the completion of the sale, the insider now owns 89,769 shares in the company, valued at $7,168,952.34. The disclosure for this sale can be found here. Over the last quarter, insiders sold 75,031 shares of company stock valued at $6,103,625. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.